Search

Your search keyword '"Farci, P."' showing total 129 results

Search Constraints

Start Over You searched for: Author "Farci, P." Remove constraint Author: "Farci, P." Search Limiters Full Text Remove constraint Search Limiters: Full Text
129 results on '"Farci, P."'

Search Results

1. You are out of context!

2. Optical coherence tomography is a useful tool in the differentiation between true edema and pseudoedema of the optic disc.

3. Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC

4. Exceptional Heterogeneity in Viral Evolutionary Dynamics Characterises Chronic Hepatitis C Virus Infection.

8. Predicting response to peginterferon -2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis

11. Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting

12. Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B

13. The use of molecular assays in the management of viral hepatitis

17. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version)

19. In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells

20. Distinctive HLA-II association with primary biliary cholangitis on the Island of Sardinia

28. Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants

29. Infection with the delta agent in children.

30. On Farm Agronomic and First Environmental Evaluation of Oil Crops for Sustainable Bioenergy Chains

31. Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels

32. Long-term benefit of interferon @a therapy of chronic hepatitis D: regression of advanced hepatic fibrosis

33. A Hyperimmune Serum against a Synthetic Peptide Corresponding to the Hypervariable Region 1 of Hepatitis C Virus Can Prevent Viral Infection in Cell Cultures

34. Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees

35. Heavy metal tolerance of orchid populations growing on abandoned mine tailings: A case study in Sardinia Island (Italy).

44. Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a.

45. The Natural History of Infection with Hepatitis C Virus (HCV) in Chimpanzees: Comparison of Serologic Responses Measured with First- and Second- Generation Assays and Relationship to HCV Viremia

47. Neutralizing Antibodies to Hepatitis C Virus in Perinatally Infected Children Followed Up Prospectively

48. Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively

49. Infection with the delta agent in children

50. Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression.

Catalog

Books, media, physical & digital resources